2022 Q3 Form 10-Q Financial Statement

#000149315222023052 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $180.00
YoY Change -99.02%
Cost Of Revenue $15.10K
YoY Change -36.31%
Gross Profit -$14.92K
YoY Change 177.84%
Gross Profit Margin -8288.89%
Selling, General & Admin $66.71K $179.5K $54.59K
YoY Change 67.57% 1199.42% -44.22%
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $76.91K $692.2K $54.58K
YoY Change 4427.85% -40.94%
Operating Profit -$76.91K -$692.2K -$69.50K
YoY Change -6906.46% 5896.98% -28.92%
Interest Expense $5.646K $5.598K -$40.40K
YoY Change -126.82% 370.03% 196.19%
% of Operating Profit
Other Income/Expense, Net $3.235K $537.5K $77.74K
YoY Change -99.91% -5045.62% -698.92%
Pretax Income -$73.68K -$154.7K -$30.68K
YoY Change -102.21% 590.24% -85.85%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$73.68K -$154.7K -$30.68K
YoY Change -102.21% 590.24% -85.85%
Net Earnings / Revenue -17045.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.248K -$2.872K -$554.30
COMMON SHARES
Basic Shares Outstanding 59.38M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.210K $20.32K $26.94K
YoY Change -95.2% 105.88% 66.71%
Cash & Equivalents $1.205K $20.32K $26.94K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.205K $20.32K $26.94K
YoY Change -97.45% -38.06% -38.78%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $354.6K $300.0K $50.00K
YoY Change 5627.9% 4746.53% 165.34%
Total Long-Term Assets $354.6K $300.0K $50.00K
YoY Change 5618.66% 4746.53% 143.24%
TOTAL ASSETS
Total Short-Term Assets $1.205K $20.32K $26.94K
Total Long-Term Assets $354.6K $300.0K $50.00K
Total Assets $355.8K $320.3K $76.94K
YoY Change 564.6% 721.34% 19.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $175.5K $185.9K $202.3K
YoY Change 1.85% 7.88% 16.25%
Accrued Expenses $181.9K $174.2K $311.6K
YoY Change -79.53% -95.92% 32.99%
Deferred Revenue
YoY Change
Short-Term Debt $1.069M $867.8K $682.5K
YoY Change 58.99% 40.47% 7.0%
Long-Term Debt Due $780.7K
YoY Change
Total Short-Term Liabilities $2.383M $2.280M $1.882M
YoY Change 37.51% -54.93% -63.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.383M $2.280M $1.882M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.383M $2.280M $1.882M
YoY Change 37.51% -54.93% -63.03%
SHAREHOLDERS EQUITY
Retained Earnings -$30.35M -$30.28M -$30.12M
YoY Change -9.53%
Common Stock $59.05K $28.32M $28.32M
YoY Change 55911.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.028M -$1.960M -$1.805M
YoY Change
Total Liabilities & Shareholders Equity $355.8K $320.3K $76.94K
YoY Change 564.6% 721.34% 19.17%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$73.68K -$154.7K -$30.68K
YoY Change -102.21% 590.24% -85.85%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$219.1K -$156.6K -$122.7K
YoY Change -1527.49% 332.9% 234.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0K $150.0K 135.0K
YoY Change 432.39% 220.51%
NET CHANGE
Cash From Operating Activities -219.1K -$156.6K -122.7K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 200.0K $150.0K 135.0K
Net Change In Cash -19.12K -$6.619K 12.35K
YoY Change -224.56% 5.2% 127.44%
FREE CASH FLOW
Cash From Operating Activities -$219.1K -$156.6K -$122.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001538495
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 ETST Stock Issued During Period Value Officer Compensation
StockIssuedDuringPeriodValueOfficerCompensation
usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q1 ETST Stock Issued During Period Value Officer Compensation
StockIssuedDuringPeriodValueOfficerCompensation
usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q2 ETST Stock Issued During Period Value Officer Compensation
StockIssuedDuringPeriodValueOfficerCompensation
usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2021Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2021Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q1 ETST Accrued Receiver Fees
AccruedReceiverFees
usd
CY2022Q2 ETST Promissory Note
PromissoryNote
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022Q2 ETST Cost Of Legal Proceedings
CostOfLegalProceedings
usd
CY2021Q2 ETST Interest Income Expense Bank Loan
InterestIncomeExpenseBankLoan
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2021Q2 ETST Stock Issued During Period Value Officer Compensation
StockIssuedDuringPeriodValueOfficerCompensation
usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2021Q3 ETST Stock Issued During Period Value Officer Compensation
StockIssuedDuringPeriodValueOfficerCompensation
usd
CY2022Q2 dei Entity File Number
EntityFileNumber
000-55000
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
EARTH SCIENCE TECH, INC.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0931484
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
10650 NW 29th Terrace
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Doral
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33172
CY2022Q2 dei City Area Code
CityAreaCode
(786)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
375-7281
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59383056 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20323 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26942 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
101404 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
20323 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
26942 usd
CY2022Q2 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
250000 usd
CY2022Q1 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
25000 usd
CY2022Q2 ETST Prepaid Acquisition Costs
PrepaidAcquisitionCosts
50000 usd
CY2022Q1 ETST Prepaid Acquisition Costs
PrepaidAcquisitionCosts
25000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
300000 usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50000 usd
CY2022Q2 us-gaap Assets
Assets
320323 usd
CY2022Q1 us-gaap Assets
Assets
76942 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
185912 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
202270 usd
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
31750 usd
CY2022Q2 ETST Accrued Receiver Fees
AccruedReceiverFees
60309 usd
CY2022Q2 ETST Loans Payablea Advance
LoansPayableaAdvance
50000 usd
CY2022Q1 ETST Loans Payablea Advance
LoansPayableaAdvance
50000 usd
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
250000 usd
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
50000 usd
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
104519 usd
CY2022Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
106800 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
174227 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
311610 usd
CY2022Q2 ETST Accrued Legal Settlement
AccruedLegalSettlement
540886 usd
CY2022Q1 ETST Accrued Legal Settlement
AccruedLegalSettlement
584886 usd
CY2022Q1 ETST Promissory Note
PromissoryNote
30000 usd
CY2022Q2 ETST Short Term Bank Loans And Notes Payables
ShortTermBankLoansAndNotesPayables
6252 usd
CY2022Q2 ETST Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
59558 usd
CY2022Q1 ETST Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
59558 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
110363 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1895 usd
CY2022Q2 ETST Note Payable Current
NotePayableCurrent
27500 usd
CY2022Q1 ETST Note Payable Current
NotePayableCurrent
27500 usd
CY2022Q2 ETST Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
59558 usd
CY2022Q1 ETST Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
59558 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2280418 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1882355 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53851966 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53851966 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53851966 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53851966 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
53353 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
50853 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28264452 usd
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28264452 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30278400 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30123718 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1960095 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1805413 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
320323 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76942 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7490 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
3745 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
3745 usd
CY2022Q2 us-gaap Officers Compensation
OfficersCompensation
31250 usd
CY2021Q2 us-gaap Officers Compensation
OfficersCompensation
5712 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142997 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7196 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
5200 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
900 usd
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1712 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
512725 usd
CY2021Q2 ETST Cost Of Legal Proceedings
CostOfLegalProceedings
-233 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
692172 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
15287 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-692172 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11542 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
547608 usd
CY2021Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
294 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
5598 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1191 usd
CY2022Q2 ETST Interest Income Expense Bank Loan
InterestIncomeExpenseBankLoan
-3971 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
537490 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10868 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-154682 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22410 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-154682 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22410 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-5026848 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
28175 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22410 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5021083 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3341399 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1679684 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-115048 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1748732 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-30681 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1805413 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-154682 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1960095 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-154682 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22410 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
250000 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13817 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
295000 usd
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3745 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-46937 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31331 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-156619 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36179 usd
CY2021Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1712 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1712 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28175 usd
CY2022Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28175 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6619 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6292 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26942 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16161 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20323 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9869 usd
CY2022Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
137850 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
5200 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
512725 usd
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zFeGy5eQOiPh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_z5XUA1lpBQTe">Use of estimates and assumptions</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s significant estimates and assumptions include the fair value of financial instruments; the accrual of the legal settlement, the carrying value recoverability and impairment, if any, of long-lived assets, including the estimated useful lives of fixed assets; the valuation allowance of deferred tax assets; stock-based compensation, the valuation of the inventory reserves and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q2 us-gaap Legal Fees
LegalFees
27000 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
547608 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
5598 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
1191 usd
CY2022Q2 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6150613 usd
CY2022Q2 ETST Net Operating Loss Carry Forwards Expiration Date
NetOperatingLossCarryForwardsExpirationDate
the year 2039 when the NOL’s will expire
CY2022Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2021Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142997 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7196 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2022Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zeL5WNQrEM5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zXptK4pb9Gqj">Reclassification</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts from the prior period have been reclassified to conform to the current period presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30278400 usd
CY2021Q3 us-gaap Area Of Land
AreaOfLand
1000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd

Files In Submission

Name View Source Status
0001493152-22-023052-index-headers.html Edgar Link pending
0001493152-22-023052-index.html Edgar Link pending
0001493152-22-023052.txt Edgar Link pending
0001493152-22-023052-xbrl.zip Edgar Link pending
etst-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
etst-20220630_def.xml Edgar Link unprocessable
etst-20220630_lab.xml Edgar Link unprocessable
etst-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
etst-20220630_cal.xml Edgar Link unprocessable